Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

New medications could improve treatment for severe alopecia areata in Australia.

Rituximab improved her dermatomyositis better than usual treatments.

Etanercept effectively treated a severe skin condition when other treatments failed.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.